Are the Newer Carbapenems of Any Value against Tuberculosis
Our aim was to assess whether newer carbapenems with a better administration profile than meropenem (ertapenem, faropenem and tebipenem) were more effective against <i>Mycobacterium tuberculosis</i> including M/XDRTB and determine if there was a synergistic/antagonistic effect with amoxi...
Gardado en:
| Main Authors: | , |
|---|---|
| Formato: | Libro |
| Publicado: |
MDPI AG,
2022-08-01T00:00:00Z.
|
| Subjects: | |
| Acceso en liña: | Connect to this object online. |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
Internet
Connect to this object online.3rd Floor Main Library
| Número de Clasificación: |
A1234.567 |
|---|---|
| Copia 1 | Dispoñible |